Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2003
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232833 Benzofuran derivatives
12/18/2003US20030232826 Amidino and guanidino peptidyl compounds
12/18/2003US20030232823 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
12/18/2003US20030232816 Benzimidazole derivatives
12/18/2003US20030232814 Novel compounds and their use
12/18/2003US20030232811 Anthranilic acid derivative
12/18/2003US20030232809 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232807 Dietetic agents
12/18/2003US20030232802 Aryl and heteroaryl sulfonates
12/18/2003DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents
12/18/2003CA2497609A1 Non-peptidic brs-3 agonists
12/18/2003CA2488798A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003CA2487430A1 Electroluminescent device
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof
12/17/2003EP1371648A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1370682A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
12/17/2003EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
12/17/2003EP1370557A1 Benzimidazole anti-inflammatory compounds
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370528A1 Mch antagonists and their use in the treatment of obesity
12/17/2003EP1370510A2 Hiv integrase inhibitors
12/17/2003EP1370270A2 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
12/17/2003EP1370258A2 Peptide deformylase inhibitors
12/17/2003EP1370250A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
12/17/2003EP1370139A2 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1109799B1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/17/2003EP1098878B1 Bispiperidines as antithrombotic agents
12/17/2003EP1001943B1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
12/17/2003EP0934276B1 Anthranilic acid derivatives as multi drug resistance modulators
12/17/2003CN1131217C Phenylazole compound, process for producing the same and drugs for hyperlipemia
12/17/2003CN1131215C Cyclic and heterocyclic n-substituted 'alpha'-iminoh-ydroxamic acid and carboxylic acids
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/16/2003US6664275 C10 heterosubstituted acetate taxanes
12/16/2003US6664274 Piperidine derivatives as serotonine reuptake inhibitors
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664269 Isoquinolinone derivatives
12/16/2003US6664258 Spirocyclic dopamine receptor subtype ligands
12/16/2003US6664256 Interleukin- 1 beta inhibitors
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6664253 Neurokinin antagonists
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6663901 Itraconazole; sugar core, a coating film of a water soluble polymer, a seal coating
12/16/2003US6663847 Administering to mammal effective amount of cyanine dye for performing diagnostic or therapeutic procedure
12/16/2003CA2275299C Indane or dihydroindole derivatives
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003101983A1 Tetrahydropyran derivative
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101968A1 Pyrazole compound and medicinal composition containing the same
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
12/11/2003WO2003101941A2 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
12/11/2003WO2003101444A1 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
12/11/2003WO2003064382A3 Process for the manufacture of organic compounds
12/11/2003WO2003045909A3 Methods and intermediates for the synthesis of azepines
12/11/2003WO2003032912A3 Treatment of cns disorders using cns target modulators
12/11/2003WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003024926A3 Methods and compositions of novel triazine compounds
12/11/2003WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/11/2003WO2002088114A3 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
12/11/2003WO2002083067A3 Prodrugs via acylation with cinnamate
12/11/2003US20030229130 Imidazolinylmethyl aralkylsulfonamides
12/11/2003US20030229125 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators
12/11/2003US20030229123 2-(Substituted-phenyl)amino-imidazoline derivatives
12/11/2003US20030229118 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
12/11/2003US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents
12/11/2003US20030229103 Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229097 Potentiation of fungicides
12/11/2003US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229077 Nitrogen-containing heterocyclic compounds
12/11/2003US20030229074 Metabolism; eating disorders; sexual disorders
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003US20030229002 Use of agents that modulate PDE11A activity
12/11/2003US20030228982 Substituted phenyl derivatives
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
1 ... 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 ... 694